// COMPANY
Nexus Venture Partners
// RECENT MENTIONS
// SIGNALS
2 SIGNALS
01
funding·PitchBook News·AUGUST 19, 2026
“Abcuro, a Massachusetts-based developer of immunotherapies for autoimmune diseases, raised a $66 million Series D led by New Leaf Venture Partners.”
02
funding·PostRound·AUGUST 10, 2026
“Naïve: AI platform for autonomous employees and business automation, $28.5M from Nexus Venture Partners”
AI-extracted from podcast / newsletter / paper summaries. May contain errors.